GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
AKR1C2 | 385 | HTM/LTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0053 | 26351321
|
TMEM45A | 25480 | HTM/LTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0053 | 26351321
|
ABCB1 | 40 | LTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA and qRT-PCR | NA | 0.2 | 0.0604 | 26351321
|
ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by qRT-PCR | NA | 0.2 | 0.1739 | 26351321
|
ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by qRT-PCR | NA | 0.2 | 0.684 | 26351321
|
CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by qRT-PCR | NA | 0.2 | 1 | 26351321
|
ABI3BP | 17265 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26351321
|
BLID | 33495 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26351321
|
CALB2 | 1435 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26351321
|
CCDC80 | 30649 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26351321
|
CCL2 | 10618 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Up | 0.04 | 0.0074 | 26351321
|
CROT | 2366 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26351321
|
CSF1 | 2432 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26351321
|
DUSP6 | 3072 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26351321
|
ENPP1 | 3356 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26351321
|
ETV1 | 3490 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26351321
|
FGFR1 | 3688 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26351321
|
FGFR2 | 3689 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26351321
|
FST | 3971 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26351321
|
HMOX1 | 5013 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26351321
|
IL6 | 6018 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Up | 0.04 | 0.0191 | 26351321
|
LCN2 | 6526 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26351321
|
MIRLET7A2 | 31477 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26351321
|
PLXNA4 | 9102 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26351321
|
PRSS2 | 9483 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26351321
|
ROR2 | 10257 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26351321
|
SLC14A1 | 10918 | HTM | Non Small Cell Lung Cancer | Carcinoma | EBC-1 | PHA-665752 | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26351321
|